Limo Chen
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
Papers in
-
- Immunotherapy and Immune Responses 3
- Oncology 9
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 3
- Co-authors
- Don Lynn Gibbons (7 shared papers)Lixia Diao (6 shared papers)Lauren Byers (5 shared papers)Jing Wang (5 shared papers)Ignacio Ivan Wistuba (3 shared papers)John Victor Heymach (3 shared papers)B. Leticia Rodriguez (4 shared papers)Edwin Roger Parra (2 shared papers)
- Journals
- Nature Communications (3 papers)Cancer Discovery (2 papers)OncoImmunology (2 papers)Oncotarget (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Limo Chen
23 papers receiving 3.2k citations
Limo Chen's Hit Papers
Peers
Comparison fields: 5 of 102
- Oncology 1.7k
- Immunology 1.1k
- Cancer Research 492
- Physiology 148
- Molecular Biology 1.2k
Countries citing papers authored by Limo Chen
This map shows the geographic impact of Limo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limo Chen more than expected).
Fields of papers citing papers by Limo Chen
This network shows the impact of papers produced by Limo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limo Chen. The network helps show where Limo Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Limo Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression Hit paper breakdown → | 2014 | 834 |
| 2 | Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer Hit paper breakdown → | 2019 | 715 |
| 3 | 2018 | 390 | |
| 4 | 2016 | 374 | |
| 5 | 2020 | 340 | |
| 6 | 2011 | 102 | |
| 7 | 2012 | 94 | |
| 8 | 2021 | 58 | |
| 9 | 2013 | 45 | |
| 10 | 2011 | 44 | |
| 11 | 2015 | 29 | |
| 12 | 2010 | 28 | |
| 13 | 2005 | 25 | |
| 14 | 2020 | 24 | |
| 15 | 2016 | 24 | |
| 16 | 2015 | 24 | |
| 17 | 2018 | 24 | |
| 18 | 2013 | 23 | |
| 19 | 2014 | 23 | |
| 20 | 2005 | 19 |
About Limo Chen
Limo Chen is a scholar working on Immunology, Oncology, Molecular Biology, Physiology and Cancer Research, having authored 23 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Cells and Metastasis (3 papers), RNA regulation and disease (3 papers), Immunotherapy and Immune Responses (3 papers), RNA and protein synthesis mechanisms (3 papers), Biochemical and Molecular Research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Oncology (1.7k citations), Immunology (1.1k citations), Cancer Research (492 citations), Physiology (148 citations) and Molecular Biology (1.2k citations). Limo Chen has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Don Lynn Gibbons, Lixia Diao, Lauren Byers, Jing Wang, Ignacio Ivan Wistuba, John Victor Heymach, B. Leticia Rodriguez, Edwin Roger Parra, Carmen Behrens and Yongbin Yang. Their work appears in journals such as Nature Communications, Cancer Discovery, OncoImmunology, Oncotarget and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.